R 626 (Zafirlukast 20 mg)
Pill imprint R 626 has been identified as Zafirlukast 20 mg.
Zafirlukast is used in the treatment of asthma, maintenance and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Zafirlukast 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for R 626 (Zafirlukast 20 mg)
- 20 mg
- Prescription only
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
sodium starch glycolate type A potato
Zafirlukast is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...